- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- IPO Date
- Mar 20, 2012
Highlights
- Market Cap
- $91.37M
- Enterprise Value
- $109.89M
- EPS (TTM)
- $0.02
- PE Ratio
- 50.44
- Total Revenue (TTM)
- $62.06M
- Gross Profit (TTM)
- $16.06M
- EBITDA (TTM)
- $3.48M
- Year Range
- $0.78 - $5.63
- ROA (TTM)
- 3.58%
- ROE (TTM)
- 10.15%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
SLSN Performance Chart
Solesence, Inc (SLSN) is down 21.3% since the beginning of the year. At $1 per share, SLSN is trading 77.7% below its 52-week high of $6. Investors who bought $1,000 worth of SLSN shares 5 years ago would now be looking at an investment worth $730.
Loading charts...
Returns By Period
Solesence, Inc (SLSN) has returned -21.32% so far this year and -69.90% over the past 12 months. Over the last ten years, SLSN has returned 9.21% per year, falling short of the S&P 500 Index benchmark, which averaged 13.66% annually.
Solesence, Inc
- 1D
- -9.71%
- 1M
- -2.33%
- YTD
- -21.32%
- 6M
- -40.80%
- 1Y
- -69.90%
- 3Y*
- -3.58%
- 5Y*
- -6.11%
- 10Y*
- 9.21%
Benchmark (S&P 500 Index)
- 1D
- -0.74%
- 1M
- 4.90%
- YTD
- 10.35%
- 6M
- 10.28%
- 1Y
- 26.52%
- 3Y*
- 20.83%
- 5Y*
- 12.30%
- 10Y*
- 13.66%
SLSN Monthly Returns History
Based on dividend-adjusted daily data since Mar 20, 2012, SLSN's average daily return is +0.27%, while the average monthly return is +3.14%. At this rate, an investment would double in approximately 1.9 years.
Historically, 51% of months were positive and 49% were negative. The best month was Apr 2018 with a return of +141.3%, while the worst month was Mar 2020 at -40.0%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 7 months.
On a daily basis, SLSN closed higher 39% of trading days. The best single day was Apr 29, 2020 with a return of +81.0%, while the worst single day was May 6, 2020 at -34.7%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -15.36% | -5.19% | -25.89% | 41.26% | -8.21% | 2.03% | -21.32% | ||||||
| 2025 | 20.34% | -3.74% | -27.56% | 51.22% | 24.52% | 12.95% | -21.33% | 6.71% | -12.02% | 1.55% | -29.97% | -30.35% | -34.71% |
| 2024 | -12.50% | 61.43% | -17.29% | 92.58% | 18.52% | -3.12% | 0.00% | -4.90% | 10.12% | 15.82% | 44.68% | -10.18% | 307.17% |
| 2023 | -2.65% | 30.00% | -10.49% | -26.60% | 27.73% | 16.13% | -6.72% | -21.92% | -13.79% | -1.13% | -13.31% | -20.00% | -46.90% |
| 2022 | -32.95% | 14.92% | 9.14% | -25.68% | 16.36% | -7.50% | 4.05% | -11.04% | -13.50% | 0.21% | -34.32% | -27.56% | -74.32% |
| 2021 | 7.65% | 8.20% | 22.22% | 33.06% | -2.48% | 7.01% | 43.15% | 0.00% | 13.93% | 16.79% | 24.53% | 10.41% | 417.65% |
Benchmark Metrics
Solesence, Inc has an annualized alpha of 89.73%, beta of 0.32, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since March 21, 2012.
- This stock participated in 85.79% of S&P 500 Index downside but only 84.64% of its upside - more exposed to losses than it benefited from rallies.
- Beta of 0.32 may look defensive, but with R2 of 0.00 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 89.73%
- Beta
- 0.32
- R²
- 0.00
- Upside Capture
- 84.64%
- Downside Capture
- 85.79%
Return for Risk
Risk / Return Rank
SLSN ranks 13 for risk / return — in the bottom 13% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Solesence, Inc (SLSN) and compare them to S&P 500 Index.
| SLSN | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.68 | 2.24 | -2.92 |
Sortino ratioReturn per unit of downside risk | -0.95 | 3.07 | -4.03 |
Omega ratioGain probability vs. loss probability | 0.89 | 1.41 | -0.51 |
Calmar ratioReturn relative to maximum drawdown | -0.83 | 2.93 | -3.76 |
Martin ratioReturn relative to average drawdown | -1.21 | 13.52 | -14.74 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Solesence, Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Solesence, Inc was 90.27%, occurring on Jan 23, 2024. Recovery took 352 trading sessions.
The current Solesence, Inc drawdown is 75.91%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2024 bear market2024 | -90.27%Jan 2024 | 2y 18d | 1y 4mo | 3y 5moJan 2022 - Jun 2025 |
COVID crash2020 | -86.61%Apr 2020 | 1y 11mo | 11mo 24d | 2y 11moApr 2018 - Apr 2021 |
2026 bear market2026 | -84.44%Mar 2026 | 8mo 28d | — | 11mo 16dJun 2025 - now |
2012 bear market2012 | -52.60%Nov 2012 | 6mo 21d | 6mo 27d | 1y 1moApr 2012 - May 2013 |
2018 bear market2018 | -51.19%Jan 2018 | 1y 5mo | 2mo 19d | 1y 8moAug 2016 - Apr 2018 |
Drawdown Indicators
| SLSN | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -90.27% | -56.78% | -33.49% |
Max Drawdown (1Y)Largest decline over 1 year | -84.44% | -9.10% | -75.34% |
Max Drawdown (3Y)Largest decline over 3 years | -84.44% | -18.90% | -65.54% |
Max Drawdown (5Y)Largest decline over 5 years | -90.27% | -25.43% | -64.84% |
Max Drawdown (10Y)Largest decline over 10 years | -90.27% | -33.92% | -56.35% |
Current DrawdownCurrent decline from peak | -75.91% | -0.74% | -75.17% |
Average DrawdownAverage peak-to-trough decline | -38.87% | -10.72% | -28.15% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 57.56% | 1.97% | +55.59% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Solesence, Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Solesence, Inc is priced in the market compared to other companies in the Household & Personal Products industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for SLSN, comparing it with other companies in the Household & Personal Products industry. Currently, SLSN has a P/E ratio of 50.4. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for SLSN relative to other companies in the Household & Personal Products industry. Currently, SLSN has a P/S ratio of 1.5. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for SLSN in comparison with other companies in the Household & Personal Products industry. Currently, SLSN has a P/B value of 5.2. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with SLSN
Add Solesence, Inc to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with SLSN